Akilia Partners Logo

Medtech

Vascular Graft Solutions

Improving the standard-of-care in cardiovascular surgery

Problem

Coronary artery bypass grafting (CABG) remains the most common cardiac surgery performed today worldwide. However, over 50% of interventions will present vein graft failure in a 10-year timespan post-intervention, leading to complications and the need for re-interventions.

Investment Rationale

Founded in 2009 by serial entrepreneur Dr. Eyal Orion, VGS is the leading developer of innovative technologies to improve surgical re-vascularization, vascular reconstruction procedures, and arteriovenous fistula.

The team knowledge, Eyal capabilities, and market knowledge have allowed the company to bring 4 products to market with limited funding.

Country
Israel
First Investment Date

2018 - 2023

Rounds Invested

Series C